Startseite UR
![]() | Eine Stufe nach oben |
Cigliano, Antonio, Zhang, Shanshan, Ribback, Silvia, Steinmann, Sara, Sini, Marcella, Ament, Cindy E., Utpatel, Kirsten, Song, Xinhua, Wang, Jingxiao
, Pilo, Maria G., Berger, Fabian, Wang, Haichuan
, Tao, Junyan, Li, Xiaolei, Pes, Giovanni M.
, Mancarella, Serena, Giannelli, Gianluigi, Dombrowski, Frank, Evert, Matthias, Calvisi, Diego F., Chen, Xin und Evert, Katja
(2022)
The Hippo pathway effector TAZ induces intrahepatic cholangiocarcinoma in mice and is ubiquitously activated in the human disease.
Journal of Experimental & Clinical Cancer Research 41, art.no.192.
, Grossi, Valentina, Simone, Cristiano, Armentano, Raffaele, Evert, Matthias, Calvisi, Diego F. und Giannelli, Gianluigi
(2022)
CD90 is regulated by notch1 and hallmarks a more aggressive intrahepatic cholangiocarcinoma phenotype.
Journal of Experimental & Clinical Cancer Research 41 (1).
Volltext nicht vorhanden.
, Ribback, Silvia, Wang, Jingxiao, Chen, Xin, Calvisi, Diego F. und Giannelli, Gianluigi
(2020)
Crenigacestat, a selective NOTCH1 inhibitor, reduces intrahepatic cholangiocarcinoma progression by blocking VEGFA/DLL4/MMP13 axis.
Cell Death & Differentiation 27 (8), S. 2330-2343.
Volltext nicht vorhanden.
Publikationsserver
Publizieren: oa@ur.de
0941 943 -4239 oder -69394
Dissertationen: dissertationen@ur.de
0941 943 -3904
Forschungsdaten: datahub@ur.de
0941 943 -5707